Fernández Domínguez MJ, Hernández Gómez MA, Garrido Barral A, González Moneo MJ. [Making balances between the risks and benefits of pharmacological treatment in dementia, chronic pain and anticoagulation in elderly persons].
Aten Primaria 2018;
50 Suppl 2:39-50. [PMID:
30563624 PMCID:
PMC6836956 DOI:
10.1016/j.aprim.2018.09.003]
[Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2018] [Revised: 08/19/2018] [Accepted: 09/05/2018] [Indexed: 11/20/2022] Open
Abstract
In dementia, specific drugs and psychotropic drugs used for psychotic and behavioral symptoms have limited efficacy. Adverse effects may be important given the age and comorbidity of the patients. It is necessary, frequently, its withdrawal, planned together with the family, monitoring the response and offering non-pharmacological treatment alternatives. Chronic pain is suffered by 25-76% of the elderly who live in a community and is more frequent in women. The treatment is multidisciplinary, establishing realistic objectives, individualizing it, starting with lower doses of drugs and continuously reevaluating to control side effects and to get the correct level of analgesia. The prevalence of atrial fibrillation increases with age and is underdiagnosed. ACO is recommended with dicoumarin or direct oral anticoagulants not antagonists of vitamin K, in patients with AF older than 65 years unless contraindicated, to reduce embolic risk, confirming subgroup analyzes similar efficacy in prevention of stroke.
Collapse